Markets and consumers were cheered as Pfizer reported that ithe Covid-19 vaccine candidate its is developing in partnership with BioNTech has an efficacy rate of above 90%.

But what do we know about the vaccine? And what does this mean for the vaccine race?

Prime Time's Rachel Kelly spoke to Beau No-af-shar, Senior Pharmaceuticals & Healthcare Analyst, Fitch Solutions to find out.

 

Markets and consumers were cheered as Pfizer reported that ithe Covid-19 vaccine candidate its is developing in partnership with BioNTech has an efficacy rate of above 90%.
But what do we know about the vaccine? And what does this mean for the vaccine race?
Prime Time's Rachel Kelly spoke to Beau No-af-shar, Senior Pharmaceuticals &amp; Healthcare Analyst, Fitch Solutions to find out.
&nbsp;

Advertisement